Data Material

ALK Medical Affairs North America provides the resources found on this website for U.S. healthcare professionals only.

Back to Results

Published: February 1, 2002

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)

Journal Publication

Topic: Dosing, SCIT

Allergen: Pollen

Authors: Christian Möller, MD, PhD, Sten Dreborg, MD, PhD, Hosne A. Ferdousi, MD, Susanne Halken, MD, Arne Høst, MD, PhD, Lars Jacobsen, MSc, Antti Koivikko, MD, PhD,g Dieter Y. Koller, MD, Bodo Niggemann, MD, Lene A. Norberg, MD, Radvan Urbanek, MD, PhD,h Erkka Valovirta, MD, PhD, and Ulrich Wahn, MD, PhDi

Click to view

By clicking here, you agree to visiting a site maintained by a third party, who is solely responsible for its contents.

Back to Results

You are leaving

The link opens a new tab

Data Material

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study)